Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
33 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
BOEHRINGER INGELHEIM CENTRE SA from Elsene, company number BE0448020729, closed financial year 2025 with a result of € 91,861 after tax. Compared with financial year 2024, the result moved from € 100,623 to € 91,861. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.
€ 1.5 million
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 91,861
▼ 9% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 1.5 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 6,006
Supplier invoices still open on the last day of the fiscal year.
€ 4,656
▲ 17% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Profit after taxes | € 69,275 | € 86,451 | € 100,623 | € 91,861 | ▼ 9% |
| Equity | € 1,261,498 | € 1,347,949 | € 1,448,572 | € 1,540,433 | ▲ 6% |
| Total debts | € 1,364 | € 3,168 | € 3,979 | € 10,662 | ▲ 168% |
| Retained profit | € 1,199,498 | € 1,285,949 | € 1,386,572 | € 1,478,433 | ▲ 7% |
| Balance sheet total | € 1,262,862 | € 1,351,117 | € 1,452,551 | € 1,551,095 | ▲ 7% |
Key figures of BOEHRINGER INGELHEIM CENTRE SA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BOEHRINGER INGELHEIM CENTRE SA?
What happened at BOEHRINGER INGELHEIM CENTRE SA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Lukas Hauschild stepped down as director. NBB
- Carla Ramon stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 91,861 (▼ 9% vs 2024). Source: NBB ↗
- Christoph Tautphäus stepped down as director. NBB
- Lukas Hauschild became a director. NBB
- Larisa Nurkanovic stepped down as director. NBB
- Sebastian Guijarro stepped down as director. NBB
- Larisa Nurkanovic became a director. NBB
In short
From € 69,275 profit in 2022 to € 91,861 profit in 2025.
Paid € 116,565 in corporate taxes since 2022.
Best year ever: 2024, with € 100,623 profit.
A new publication or filing at BOEHRINGER INGELHEIM CENTRE SA? We notify you, reason included.
Follow BOEHRINGER INGELHEIM CENTRE SADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Boehringer Ingelheim International GmbH and Boehringer Ingelheim GmbH.
Directors
According to the 2025 annual accounts
Sebastian Guijarro
Director
Also active at: Boehringer Ingelheim SComm, Boehringer Ingelheim Animal Health Belgium SA
since 2024 · until 2025
Chiedza Kaitano
Director, Managing director
Also active at: Boehringer Ingelheim Veterinary Medicine Belgium NV
since 2024 · until 2025
Larisa Nurkanovic
Managing director
Also active at: Boehringer Ingelheim Veterinary Medicine Belgium NV
since 2025 · until 2026
Carla Ramon
Managing director
since 2025 · until 2029
Christoph Tautphäus
Director
Also active at: Boehringer Ingelheim SComm, Boehringer Ingelheim Veterinary Medicine Belgium NV
since 2025 · until 2026
Lukas Hauschild
Director
Also active at: Boehringer Ingelheim SComm, Boehringer Ingelheim Animal Health Belgium SA
since 2026 · until 2031
Eva Porta Soldevila
Director, Managing director
since 2023 · until 2025
Shareholders
Boehringer Ingelheim International GmbH
Boehringer Ingelheim GmbH
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Arnaud Fraiteurlaan 15/23
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 33 companies are registered at this address.
All companies at this address →Laboratoires Titra
€ -7,222 gross margin · 2024
Boehringer Ingelheim SComm same network
€ 164.7 million revenue · 2025
Boehringer Ingelheim Animal Health Belgium SA same network
€ 50.6 million revenue · 2025
A.J.B. INTERIEUR
€ 26,086 gross margin · 2025
Krys Construct
€ 25,462 gross margin · 2024
+28 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0448.020.729
- VAT number
- BE 0448.020.729
- Registered office
- Arnaud Fraiteurlaan 15/23, 1050 Elsene
- Names & denominations
- BOEHRINGER INGELHEIM CENTRE SA
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 August 1992
- Peppol
- Active · Active since 13 Mar 2026